EU
#Migration and #Asylum - EU funds to promote integration and protect borders
Published
2 years agoon

MEPs backed on Tuesday (19 February) increasing the EU budget for migration and asylum policies and to reinforce borders.
The Civil Liberties Committee endorsed the renewed Asylum, Migration and Integration Fund (AMIF), the 2021-2027 budget of which will increase up to €9.2 billion (€10.41bn in current prices, 51% more than in the previous financial framework). It also backed the creation of a new Integrated Border Management Fund (IBMF) and agreed to allocate €7.1bn (€8bn in current prices) to it.
The AMIF should contribute to strengthen the common asylum policy, develop legal migration, in line with the member states’ economic and social needs, contribute to countering irregular migration and ensure effective, safe and dignified return, readmission and reintegration in non-EU countries.
But it should also ensure “solidarity and fair sharing of responsibility between the member states, in particular towards those most affected by migration challenges, including through practical co-operation”, MEPs said.
MEPs also want to make sure that funds can be allocated to local and regional authorities, and to international and non‑governmental organizations, working in the field of asylum and migration.
Integrated Border Management Fund to secure EU's external borders
IBMF will provide funding to build and enhance member states’ capacities in border management and visa policy. The funding dedicated to member states (60 % of the total envelope) will reflect their needs and take into account additional pressures. Furthermore, a new EU thematic facility (40% of the total envelope) will ensure flexibility to channel emergency funding to member states and EU-level projects when urgent action is needed.
MEPs also added safeguards to ensure that actions and measures funded through the Instrument comply with the EU’s fundamental rights obligations, in particular with the principles of non-discrimination and non-refoulement. (COMP 3)
Both funds will operate in full synergy. They will also work closely with the reinforced Internal Security Fund (ISF) focusing on tackling terrorism, organized crime and cybercrime.
Next steps
The draft proposal on the renewed AMIF passed with 40 votes to 7 and 6 abstentions. The new IBMF was backed by 41 MEPs, 9 voted against and 2 abstained. The full House will have to confirm its position in the first March plenary, ahead of the negotiations with the Council of the EU.
You may like
-
EU approves €2.9 billion in state aid for battery project attracting €9 billion
-
Italian prime minister Giuseppe Conte resigns
-
EAPM: Big plan on beating cancer set for big launch, coronavirus restrictions tighten
-
Former MEP Kaja Kallas to become Estonia’s first female prime minister
-
EU urges AstraZeneca to speed up vaccine deliveries amid 'supply shock'
-
Brexit butchers EU trade for Scottish beef producers
Economy
EU approves €2.9 billion in state aid for battery project attracting €9 billion
Published
44 mins agoon
January 26, 2021
The Commission has approved, state aid of up to €2.9 billion in funding for an ‘Important Project of Common European Interest’ (IPCEI) to support research and innovation in the battery value chain. The twelve EU countries involved will provide public funding expected to unlock an additional €9 billion in private investments.
The project, called “European Battery Innovation” was jointly prepared and notified by Austria, Belgium, Croatia, Finland, France, Germany, Greece, Italy, Poland, Slovakia, Spain and Sweden.
€2,9bn public money crowding in €9bn for massive innovation in battery value chain - make it more sustainable. Risks can be too big for one MS/one company to take alone. Good that European governments come together to support! Benefits for the many when new knowledge is shared.
— Margrethe Vestager (@vestager) January 26, 2021
Executive Vice-President Margrethe Vestager, in charge of competition policy, said: “For those massive innovation challenges for the European economy, the risks can be too big for just one member state or one company to take alone. Today's project is an example of how competition policy works hand in hand with innovation and competitiveness. With significant support also comes responsibility: the public has to benefit from its investment, which is why companies receiving aid have to generate positive spillover effects across the EU.”
When Vestager was asked if companies from outside the EU, such as Tesla, could benefit from this funding she said that this was possible and showed that the EU was committed to open strategic autonomy and welcomes non-EU firms when they have the right projects.
The Vice-President for Foresight, Maroš Šefčovič, said: “The Commission has given its green light to a second important project of the common European interest in the field of batteries. Technology is vital for our transition to climate neutrality. The figures show what an enormous undertaking this is. It involves twelve member states from North, South, East and West, injecting up to €2.9 billion euros in state aid in support of 46 projects designed by 42 companies, which in turn will generate three times as much private investment. "
"You miss 💯% of the shots you don't take." @WayneGretzky, turning 60 today, famously said.
The success of EU #battery sector🔋 serves as a tangible testimony to that. It's defying the negative trends in our economies & we're on track towards attaining open strategic autonomy. pic.twitter.com/QBQVnTBVIa
— Maroš Šefčovič🇪🇺 (@MarosSefcovic) January 26, 2021
The project will cover the entire battery value chain: extraction of raw materials, design and manufacturing of battery cells, recycling and disposal. It is expected to contribute to the development of a whole set of new technological breakthroughs, including different cell chemistries and novel production processes, and other innovations in the battery value chain, in addition to what will be achieved thanks to the first battery IPCEI.
coronavirus
EU urges AstraZeneca to speed up vaccine deliveries amid 'supply shock'
Published
13 hours agoon
January 26, 2021
In a sign of the EU’s frustration - after Pfizer also announced supply delays earlier in January - a senior EU official told Reuters the bloc would in the coming days require pharmaceutical companies to register COVID-19 vaccine exports.
AstraZeneca, which developed its shot with Oxford University, told the EU on Friday it could not meet agreed supply targets up to the end of March, with an EU official involved in the talks telling Reuters that meant a 60% cut to 31 million doses.
“We expect the company to find solutions and to exploit all possible flexibilities to deliver swiftly,” an EU Commission spokesman said, adding the head of the EU executive Ursula von der Leyen had a call earlier on Monday with AstraZeneca’s chief Pascal Soriot to remind him of the firm’s commitments.
A spokesman for AstraZeneca said Soriot told von der Leyen the company was doing everything it could to bring its vaccine to millions of Europeans as soon as possible.
News emerged on Monday that the company faces wider supply problems.
Australia’s Health Minister Greg Hunt told reporters AstraZeneca had advised the country it had experienced “a significant supply shock”, which would cut supplies in March below what was agreed. He did not provide figures.
Thailand’s Health Minister Anutin Charnvirakul said AstraZeneca would be supplying 150,000 doses instead of the 200,000 planned, and far less than the 1 million shots the country had initially requested.
AstraZeneca declined to comment on global supply issues.
The senior EU official said the bloc had a contractual right to check the company’s books to assess production and deliveries, a move that could imply the EU fears doses being diverted from Europe to other buyers outside the bloc.
AstraZeneca has received an upfront payment of 336 million euros ($409 million) from the EU, another official told Reuters when the 27-nation bloc sealed a supply deal with the company in August for at least 300 million doses - the first signed by the EU to secure COVID-19 shots..
Under advance purchase deals sealed during the pandemic, the EU makes down-payments to companies to secure doses, with the money expected to be mostly used to expand production capacity.
“Initial volumes will be lower than originally anticipated due to reduced yields at a manufacturing site within our European supply chain,” AstraZeneca said on Friday.
The site is a viral vectors factory in Belgium run by the drugmaker’s partner Novasep.
Viral vectors are produced in genetically modified living cells that have to be nurtured in bioreactors. The complex procedure requires fine-tuning of various inputs and variables to arrive at consistently high yields.
“The flimsy justification that there are difficulties in the EU supply chain but not elsewhere does not hold water, as it is of course no problem to get the vaccine from the UK to the continent,” said EU lawmaker Peter Liese, who is from the same party as German Chancellor Angela Merkel.
The EU called a meeting with AstraZeneca after Friday’s (22 January) announcement to seek further clarification. The meeting started at 1230 CET on Monday.
The EU official involved in the talks with AstraZeneca said expectations were not high for the meeting, in which the company will be asked to better explain the delays.
Earlier in January, Pfizer, which is currently the largest supplier of COVID-19 vaccines to the EU, announced delays of nearly a month to its shipments, but hours later revised this to say the delays would last only a week.
EU contracts with vaccine makers are confidential, but the EU official involved in the talks did not rule out penalties for AstraZeneca, given the large revision to its commitments. However, the source did not elaborate on what could trigger the penalties. “We are not there yet,” the official added.
“AstraZeneca has been contractually obligated to produce since as early as October and they are apparently delivering to other parts of the world, including the UK without delay,” Liese said.
AstraZeneca’s vaccine is expected to be approved for use in the EU on Jan. 29, with first deliveries expected from 15 February.
($1 = €0.8214)
EU
Chemicals: EU protects wildlife from negative effects of lead in the environment
Published
13 hours agoon
January 26, 2021
On 25 January, the Commission took firm steps to ensure that wildlife is protected from the negative effects of lead in the environment, by restricting its use in gunshot in or around wetlands. Adopted under the framework of the EU's chemicals regulation, the measure will help to protect the environment by significantly reducing lead pollution while preventing the avoidable death by lead poisoning of around 1 million waterbirds every year. Lead is a highly toxic substance, which released to the environment contaminates both the soil and water.
Every year, 4,000 to 5,000 tonnes of lead are released into wetlands from lead gunshot. There are affordable alternatives, for example steel gunshots, which currently cost about the same as lead gunshots. The measure adopted today will harmonise and enhance the effectiveness of national legislation limiting the use of lead gunshot in wetlands already in place in 24 member states.
It will start applying in two years' time. The restriction supports the goals of the Chemical Strategy for Sustainability and the Green Deal. It also supports the objectives of the Birds Directive, and is a first concrete deliverable under the new EU 2030 Biodiversity Strategy. More info here.

EU approves €2.9 billion in state aid for battery project attracting €9 billion

Italian prime minister Giuseppe Conte resigns

EAPM: Big plan on beating cancer set for big launch, coronavirus restrictions tighten

Former MEP Kaja Kallas to become Estonia’s first female prime minister

Dutch PM condemns lockdown riots as 'criminal violence'

Head of French health regulatory body: COVID situation is 'worrying'

Bank embraces blockchain to facilitate Belt and Road trade

#EBA - Supervisor says the EU banking sector entered the crisis with solid capital positions and improved asset quality

The war in #Libya - a Russian movie reveals who is spreading death and terror

First president of #Kazakhstan Nursultan Nazarbayev’s 80th birthday and his role in international relations

EU solidarity in action: €211 million to Italy to repair the damage of the harsh weather conditions in autumn 2019

PKK’s involvement in the Armenia-Azerbaijan conflict would jeopardize European security

Kyriakides says newly proposed schedule of AstraZeneca ‘not acceptable’

‘It is not a friendly signal from the UK immediately after leaving the European Union’ Borrell

Kyriakides calls on Astra Zeneca to respect delivery schedules for its vaccine

Minister calls for Magnitsky-type sanctions in response to Russia's detention of Navalny

Leaders agree on new ‘dark red’ zones for high-risk COVID areas

Lagarde calls for swift ratification of Next Generation EU
Trending
-
Frontpage2 days ago
Memories beyond Auschwitz are more important than ever
-
Human Rights1 day ago
Persecution of The Church of Almighty God: From bad to worse
-
Environment5 days ago
United States re-joining the Paris Agreement - Statement by Executive Vice-President Frans Timmermans and High Representative/Vice President Josep Borrell
-
Environment2 days ago
UK and France can lead mobilization of tropical forest protection investment
-
Brexit2 days ago
Commission proposes to amend the EU's 2021 budget to accommodate the Brexit Adjustment Reserve
-
coronavirus2 days ago
WHO says Pfizer deal could allow poor countries to start vaccinating in February
-
Brexit1 day ago
‘It is not a friendly signal from the UK immediately after leaving the European Union’ Borrell
-
South Korea1 day ago
Panel of experts confirms the Republic of Korea is in breach of labour commitments under our trade agreement